A Jones1, C Fujiyama. Show Affiliations » 1. Department of Urology, Churchill Hospital, Oxford, UK.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useCell CommunicationExtracellular Matrix/physiologyFibroblast Growth Factor 2/metabolismHumansHypoxia/metabolismMicrocirculationNeovascularization, Pathologic/diagnosisNeovascularization, Pathologic/etiologyNeovascularization, Pathologic/therapyOncogenes/physiologyPrognosisThymidine Phosphorylase/metabolismUrogenital Neoplasms/blood supplyUrogenital Neoplasms/drug therapyUrogenital Neoplasms/metabolism
Substances: See more » Antineoplastic AgentsFibroblast Growth Factor 2Thymidine Phosphorylase
Year: 1999 PMID: 10210606 DOI: 10.1046/j.1464-410x.1999.00018.x
Source DB: PubMed Journal: BJU Int ISSN: 1464-4096 Impact factor: 5.588